Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper

Immunotherapy with checkpoint inhibitors against programmed cell death receptor (PD-1) and programmed cell death ligand (PD-L1) has been implemented in the treatment pathway of patients with non-small cell lung cancer (NSCLC) from locally advanced disease to the metastatic setting. This approach has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Gomes, Fabio, Wong, Melisa, Battisti, Nicolò Matteo Luca, Kordbacheh, Tiana, Kiderlen, Mandy, Greystoke, Alastair, Luciani, Andrea
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7492214/
https://ncbi.nlm.nih.gov/pubmed/32694695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0986-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars